378 related articles for article (PubMed ID: 35944373)
1. Hepatocellular and extrahepatic cancers in non-alcoholic fatty liver disease: A systematic review and meta-analysis.
Thomas JA; Kendall BJ; Dalais C; Macdonald GA; Thrift AP
Eur J Cancer; 2022 Sep; 173():250-262. PubMed ID: 35944373
[TBL] [Abstract][Full Text] [Related]
2. Incidence of Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review, Meta-analysis, and Meta-regression.
Orci LA; Sanduzzi-Zamparelli M; Caballol B; Sapena V; Colucci N; Torres F; Bruix J; Reig M; Toso C
Clin Gastroenterol Hepatol; 2022 Feb; 20(2):283-292.e10. PubMed ID: 33965578
[TBL] [Abstract][Full Text] [Related]
3. Incidence of hepatocellular carcinoma in nonalcoholic fatty liver disease without cirrhosis or advanced liver fibrosis.
Behari J; Gougol A; Wang R; Luu HN; Paragomi P; Yu YC; Molinari M; Chopra K; Malik SM; Geller D; Yuan JM
Hepatol Commun; 2023 Jul; 7(7):. PubMed ID: 37395730
[TBL] [Abstract][Full Text] [Related]
4. Cancer Risk in Patients With Biopsy-Confirmed Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study.
Simon TG; Roelstraete B; Sharma R; Khalili H; Hagström H; Ludvigsson JF
Hepatology; 2021 Nov; 74(5):2410-2423. PubMed ID: 33811766
[TBL] [Abstract][Full Text] [Related]
5. Incidence and predictors of hepatocellular carcinoma in NAFLD without diagnosed cirrhosis: a nationwide real-world U.S. study.
Huang DQ; Tran S; Barnett S; Zou B; Yeo YH; Cheung R; Nguyen MH
Hepatol Int; 2024 Apr; 18(2):540-549. PubMed ID: 38079023
[TBL] [Abstract][Full Text] [Related]
6. Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohorts.
Alexander M; Loomis AK; van der Lei J; Duarte-Salles T; Prieto-Alhambra D; Ansell D; Pasqua A; Lapi F; Rijnbeek P; Mosseveld M; Waterworth DM; Kendrick S; Sattar N; Alazawi W
BMC Med; 2019 May; 17(1):95. PubMed ID: 31104631
[TBL] [Abstract][Full Text] [Related]
7. Hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis: HCC and Steatosis or Steatohepatitis.
Petrelli F; Manara M; Colombo S; De Santi G; Ghidini M; Mariani M; Iaculli A; Rausa E; Rampulla V; Arru M; Viti M; Lonati V; Ghidini A; Luciani A; Facciorusso A
Neoplasia; 2022 Aug; 30():100809. PubMed ID: 35636146
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal changes in fibrosis markers are associated with risk of cirrhosis and hepatocellular carcinoma in non-alcoholic fatty liver disease.
Cholankeril G; Kramer JR; Chu J; Yu X; Balakrishnan M; Li L; El-Serag HB; Kanwal F
J Hepatol; 2023 Mar; 78(3):493-500. PubMed ID: 36402450
[TBL] [Abstract][Full Text] [Related]
9. Global incidence of adverse clinical events in non-alcoholic fatty liver disease: A systematic review and meta-analysis.
Le MH; Le DM; Baez TC; Dang H; Nguyen VH; Lee K; Stave CD; Ito T; Wu Y; Yeo YH; Ji F; Cheung R; Nguyen MH
Clin Mol Hepatol; 2024 Apr; 30(2):235-246. PubMed ID: 38281814
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular and extrahepatic cancer risk in people with non-alcoholic fatty liver disease.
Thomas JA; Kendall BJ; El-Serag HB; Thrift AP; Macdonald GA
Lancet Gastroenterol Hepatol; 2024 Feb; 9(2):159-169. PubMed ID: 38215780
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular carcinoma surveillance in patients with non-alcoholic fatty liver disease.
Seif El Dahan K; Daher D; Singal AG
Clin Mol Hepatol; 2023 Feb; 29(Suppl):S207-S219. PubMed ID: 36103899
[TBL] [Abstract][Full Text] [Related]
12. Should Patients With NAFLD/NASH Be Surveyed for HCC?
Reig M; Gambato M; Man NK; Roberts JP; Victor D; Orci LA; Toso C
Transplantation; 2019 Jan; 103(1):39-44. PubMed ID: 30080818
[TBL] [Abstract][Full Text] [Related]
13. Association of metabolic traits with occurrence of nonalcoholic fatty liver disease-related hepatocellular carcinoma: A systematic review and meta-analysis of longitudinal cohort studies.
Chen J; Song S; Li X; Bian D; Wu X
Saudi J Gastroenterol; 2022; 28(2):92-100. PubMed ID: 34810377
[TBL] [Abstract][Full Text] [Related]
14. The FIB-4 Index Predicts the Development of Liver-Related Events, Extrahepatic Cancers, and Coronary Vascular Disease in Patients with NAFLD.
Kamada Y; Munekage K; Nakahara T; Fujii H; Sawai Y; Doi Y; Hyogo H; Sumida Y; Imai Y; Miyoshi E; Ono M;
Nutrients; 2022 Dec; 15(1):. PubMed ID: 36615725
[TBL] [Abstract][Full Text] [Related]
15. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis.
Ye Q; Zou B; Yeo YH; Li J; Huang DQ; Wu Y; Yang H; Liu C; Kam LY; Tan XXE; Chien N; Trinh S; Henry L; Stave CD; Hosaka T; Cheung RC; Nguyen MH
Lancet Gastroenterol Hepatol; 2020 Aug; 5(8):739-752. PubMed ID: 32413340
[TBL] [Abstract][Full Text] [Related]
16. Non-alcoholic fatty liver disease associated with hepatocellular carcinoma: An increasing concern.
Dhamija E; Paul SB; Kedia S
Indian J Med Res; 2019 Jan; 149(1):9-17. PubMed ID: 31115369
[TBL] [Abstract][Full Text] [Related]
17. Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease.
Kanwal F; Kramer JR; Mapakshi S; Natarajan Y; Chayanupatkul M; Richardson PA; Li L; Desiderio R; Thrift AP; Asch SM; Chu J; El-Serag HB
Gastroenterology; 2018 Dec; 155(6):1828-1837.e2. PubMed ID: 30144434
[TBL] [Abstract][Full Text] [Related]
18. Rational HCC screening approaches for patients with NAFLD.
Singal AG; El-Serag HB
J Hepatol; 2022 Jan; 76(1):195-201. PubMed ID: 34508791
[TBL] [Abstract][Full Text] [Related]
19. Association between nonalcoholic fatty liver disease and extrahepatic cancers: a systematic review and meta-analysis.
Liu SS; Ma XF; Zhao J; Du SX; Zhang J; Dong MZ; Xin YN
Lipids Health Dis; 2020 May; 19(1):118. PubMed ID: 32475354
[TBL] [Abstract][Full Text] [Related]
20. A risk prediction model for hepatocellular carcinoma in non-alcoholic fatty liver disease without cirrhosis: HCC prediction for non-cirrhotic NAFLD.
Kim GA; Park Y; Oh SJ; Jung J; Han S; Chang HS; Park SW; Kim TH; Park HW; Choe J; Kim J; Lee HC
Liver Int; 2024 Mar; 44(3):738-748. PubMed ID: 38110797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]